$1.20
-0.02-1.64%
At close: -
$1.16
-0.04-3.44%
After Hours: Jun 20, 4:31 PM EDT
Comments
Loading...
Acumen Pharmaceuticals Insider Trading Activity | NASDAQ:ABOS | Benzinga
Track the latest Acumen Pharmaceuticals insider trading activity. Stay informed on recent buys, sells, and market impact for Acumen Pharmaceuticals stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Acumen Pharmaceuticals Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Acumen Pharmaceuticals Inc
Shares Outstanding
60.573M
Insider Shares Owned
1.617M
Insider Percentage Owned
2.67%
Institutional Shares Held
13.464M
Institutional Percentage Held
22.2%
| Jan 23, 2025 | Matt Zuga | CFO & CHIEF BUSINESS OFFICER | -33.27K | $1.70 | -$56.62K | SELL | -12.55% | 231.74K | Jan 21 - Jan 23 | View |
| Jan 23, 2025 | Joseph Daniel OConnell | CHIEF EXECUTIVE OFFICER | -12.62K | $1.59 | -$20.10K | SELL | -1.86% | 667.49K | Jan 21 | View |
| Jan 23, 2025 | Derek Meisner | CHIEF LEGAL OFFICER & CORP SEC | -3.42K | $1.59 | -$5.43K | SELL | -2.08% | 161.13K | Jan 21 | View |
| Jan 23, 2025 | Russell Barton | CHIEF OPERATING OFFICER | -2.91K | $1.61 | -$4.69K | SELL | -2.10% | 136.12K | Jan 21 | View |
| Jan 23, 2025 | Eric Siemers | CHIEF MEDICAL OFFICER | -3.22K | $1.59 | -$5.12K | SELL | -1.86% | 170.30K | Jan 21 | View |
| Jan 07, 2025 | Joseph Daniel OConnell | CHIEF EXECUTIVE OFFICER | 177.62K | $1.84 | -$87.87K | GRANT | 35.35% | 680.11K | Jan 03 - Jan 07 | View |
| Jan 07, 2025 | Derek Meisner | CHIEF LEGAL OFFICER & CORP SEC | 55.68K | $1.84 | -$20.51K | GRANT | 51.14% | 164.54K | Jan 03 - Jan 06 | View |
| Jan 07, 2025 | Russell Barton | CHIEF OPERATING OFFICER | 42.16K | $1.86 | -$14.23K | GRANT | 43.53% | 139.03K | Jan 03 - Jan 06 | View |
| Jan 07, 2025 | Matt Zuga | CFO & CHIEF BUSINESS OFFICER | 53.56K | $1.84 | -$24.37K | GRANT | 25.33% | 265.01K | Jan 03 - Jan 06 | View |
| Jan 07, 2025 | Eric Siemers | CHIEF MEDICAL OFFICER | 55.94K | $1.85 | -$20.05K | GRANT | 47.58% | 173.52K | Jan 03 - Jan 06 | View |
| Jan 19, 2024 | Joseph Daniel OConnell | PRESIDENT AND CEO | -15.20K | $3.47 | -$52.75K | SELL | -2.94% | 502.49K | Jan 19 | View |
| Jan 19, 2024 | Derek Meisner | CHIEF LEGAL OFFICER & CORP SEC | -8.93K | $3.48 | -$31.05K | SELL | -7.58% | 108.87K | Jan 19 | View |
| Jan 19, 2024 | Matt Zuga | CFO & CHIEF BUSINESS OFFICER | -4.24K | $3.71 | -$15.72K | SELL | -1.97% | 211.44K | Jan 18 | View |
| Jan 19, 2024 | Eric Siemers | CHIEF MEDICAL OFFICER | -3.12K | $3.71 | -$11.60K | SELL | -2.59% | 117.58K | Jan 18 | View |
| Jan 19, 2024 | Russell Barton | CHIEF OPERATING OFFICER | -2.83K | $3.73 | -$10.56K | SELL | -2.84% | 96.87K | Jan 18 | View |
| Aug 18, 2023 | Jeffrey Ives | DIRECTOR | 0.00 | $3.62 | -$240.81K | SELL-OPTIONS | 0.00% | 0.00 | Aug 17 | View |
| Jul 25, 2023 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | DIRECTOR | 5.16M | $7.75 | $40.00M | BUY | 60.93% | 13.63M | Jul 21 | View |
| Jul 08, 2021 | Paul Manning | 10% OWNER | 3.92M | $16.00 | $5.00M | BUY | ∞ | 657.99K | Jul 06 | View |
| Jul 08, 2021 | John Stalfort III | DIRECTOR | 296.77K | $16.00 | $560.00K | BUY | ∞ | 131.59K | Jul 06 | View |
| Jul 08, 2021 | Robert Hardie | 10% OWNER | 3.92M | $16.00 | $5.00M | BUY | ∞ | 657.99K | Jul 06 | View |
| Jul 08, 2021 | Robert Hardie | 10% OWNER | 3.95M | $16.00 | $12.00M | BUY | ∞ | 3.95M | Jul 06 | View |
| Jul 08, 2021 | Nathan Fountain | DIRECTOR | 6.25K | $16.00 | $100.00K | BUY | ∞ | 6.25K | Jul 06 | View |
| Jul 08, 2021 | Sands Capital Ventures Discovery Fund III LPSands Capital Global Venture Fund II LPSands Capital Life Sciences Pulse Fund LLCFRANK SANDS | 10% OWNER | 3.42M | $14.88 | $6.70M | BUY | ∞ | 3.42M | Jul 06 | View |
| Jul 08, 2021 | RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah | DIRECTOR | 9.77M | $16.00 | $30.00M | BUY | ∞ | 588.85K | Jul 06 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
